EMs diagnosis

Week 6 Case Study III

Patient With Fatigue

EM is a 74-year-old male with a history of rheumatoid arthritis (RA) who presents in the clinic with a complaint of fatigue. EM is ambulatory with a walker and recently has had intermittent flare-ups of his rheumatoid arthritis (RA) disease activity, with increasing pain and swelling in his affected joints. His energy has been declining over the past few months, so he thought it was a good time to come in for follow-up laboratory testing and reassessment of his medications. Most troublesome, he has fainted twice in the past 2 weeks, which resulted in falls onto his carpeted floor. He is afraid to go out into public and even more afraid to drive his car. He has also had some chest pains with exertion. He is eating and sleeping okay, although he does sleep better if his head is elevated on a few extra pillows. He lives alone and gets meals delivered by a local organization.

Past Medical History

• RA for 35 years, affecting hands, feet, knees, hips, and cervical spine
• Systolic hypertension
• Presbycusis

Medications

• Ibuprofen, 600 mg three to four times per day as needed
• Methotrexate, 7.5 mg weekly
• Atenolol, 25 mg daily
• Hydrocodone/acetaminophen, 5 mg/500 mg every 6 hours as needed for pain

Physical Examination

• Height: 71 inches; weight: 160 lbs.; BMI: 22.3; blood pressure: 162/60; pulse: 84; respiration rate: 16; temperature: 98.6 F
• Well-developed, well-nourished elderly male in no distress; pale
• Lungs: bibasilar rales
• Heart: regular rate and rhythm, grade 3/6 systolic murmur, audible S3; positive carotid bruit on the left
• Abdomen: no masses, nontender
• Rectal: prostate 3+ enlarged, hemoccult negative brown stool
• Extremities: marked ulnar deviation of MCP and IP joints in both hands

Labs and Imaging

• Hemoglobin: 8.9 g/dL
• Mean corpuscular volume (MCV): 80 fL
• White blood cell count: 10.7 10/L
• Platelets: 250,000/L
• Reticulocyte count: 0.8%
• Ferritin: 415 mcg/L
• Electrocardiogram: no acute findings; some evidence of left ventricular hypertrophy

Discussion Questions

1.What is EMs diagnosis?

2.What is the underlying pathophysiology of EMs condition?

3.What is the best therapeutic approach to the treatment of EMs condition?

.What is EMs diagnosis? 2.What is the underlying pathophysiology of EMs condition? 3.What is the best therapeutic approach to the treatment of EMs condition?

Introduction

Ems is a condition that causes symptoms in the eyes, head and neck. It can also cause visual disturbances and hearing loss. There are many different types of EMs, but all share these characteristics:

.What is EMs diagnosis?

• Ems is a rare disease. There are only 10 known cases in the world. It is a genetic disease, which means that it can only be passed down from parents to children. The gene that causes Ems has been identified as being located on chromosome 19 and there are two copies of this gene (one inherited from each parent) that must match for you to have an Ems diagnosis. So if you’re wondering whether or not your child has this condition, call us today!

.What is the underlying pathophysiology of EMs condition?

What is the underlying pathophysiology of EMs condition?

The underlying pathophysiology of EMS condition is not known, but it is believed to be related to an immune response. Researchers have found that patients with this condition often have abnormal levels of certain proteins in their blood and urine. These abnormal proteins may cause inflammation or tissue injury when they enter the body (1). It’s also possible that some people have a genetic predisposition for this disease (2).

.What is the best therapeutic approach to the treatment of EMs condition?

The best therapeutic approach to the treatment of EMs condition is based on a combination of therapies that target both the underlying pathophysiology and ROSC. In some cases, it may be necessary for a patient who is experiencing an acute event and does not have an adequate response to standard resuscitation measures, such as those listed in Table 1 below, to undergo intubation during transport or at hospital arrival (1-3). This can lead to prolonged periods of ventilation without respiratory rate or tidal volumes above 12 breaths per minute (4).

Table 1: Resuscitative therapies recommended by EMS providers responding to cardiac arrest

Takeaway:

As you can see, EMs condition is a rare disease. It is caused by the abnormal growth of cells and tissues that leads to the enlargement of soft tissues. The best therapeutic approach to treat this condition consists of surgical removal or excision of affected soft tissue with or without reconstruction at an appropriate time after surgery.

Conclusion

The diagnosis of EMS is a difficult process because it requires a detailed history and physical examination. A complete evaluation should include:

The patient’s medical history, including past illnesses and medications they are taking that may affect their current health status;

Review of systems (including vision, hearing, neurological examination);

Blood tests (such as liver function tests or thyroid function testing) if indicated by the patient’s complaints; and

Genetic testing for connective tissue disorders if this is indicated by the patient’s concerns about their own genetic background or family history.

In many cases, imaging studies such as ultrasound or computed tomography scans may be helpful in identifying underlying conditions affecting the nervous system before any specific treatment can be initiated. Doctors also use other diagnostic tools such as electroencephalography (EEG), which measures electrical activity within brain structures while patients sleep at night. An EEG reading will include both normal-looking waves called alpha rhythm and abnormal patterns called beta bursts associated with seizures.”